What are the treatment options for relapsed T-ALL in a patient who was nonadherent with AALL and hyper-CVAD regimens?
Is there a role for nelarabine and venetoclax in this setting?
1 Answer
Mednet MemberInvited Expert
Hematology · University of Chicago
Answered on
Regimens to consider with data for R/R T-ALL include:
- Nelarabine +/- chemotherapy. There are retrospective data to support adding nelarabine to a chemo backbone (Shimony et al., PMID 36508268 and Shimony et al., PMID 37389830).
- HMA + venetoclax (Pinton et al., PMID 37889114 and Cao et al., Blood 202...
Join for free or sign in to see the full answer